Clinical Trial Update: Phase 1 Study of EZN-2968 Weekly in Adult Patients With Advanced Solid Tumors or Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 study of EZN-2968 weekly in adults with advanced solid tumors or lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma
• Lymphoma

Drugs mentioned

• EZN-2968

Snippet

Sponsor: Enzon Pharmaceuticals, Inc. | Conditions: Carcinoma, Lymphoma | Phase 1 | Status: COMPLETED